Disclosure Of Earnings Per Share [Text Block]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Disclosure of earnings per share [text block] |
Das Ergebnis je Aktie wird nach IAS 33 auf der Basis des auf die Eigentümer der Muttergesellschaft entfallenden Jahresergebnisses der Biofrontera Gruppe sowie der während des Geschäftsjahres durchschnittlich im Umlauf befindlichen Stammaktien berechnet.
|
— |
| Earnings per share [text block] | — | — |
| Earnings per share [abstract] | ||
| Earnings per share [line items] | ||
| Basic earnings per share [abstract] | ||
| Basic earnings (loss) per share from continuing operations |
1.0000
|
77.0000
|
| Diluted earnings per share [abstract] | ||
| Diluted earnings (loss) per share from continuing operations |
1.0000
|
77.0000
|
| Adjustments to reconcile profit (loss) to numerator used in calculating earnings per share [abstract] | ||
| Profit (loss), attributable to owners of parent |
369,000
EUR
|
44,166
EUR
|
| Disclosure of depositary receipts [text block] | — | — |
| Disclosure of depositary receipts [abstract] | ||
| Disclosure of depositary receipts [line items] |